Back
Astec Industries 10K Form
Sell
25
ASTE
Astec Industries
Last Price:
32.28
Seasonality Move:
0.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | ASTE/Astec Industries Quarterly |
2023-08-03 | 10Q | ASTE/Astec Industries Quarterly |
2023-05-04 | 10Q | ASTE/Astec Industries Quarterly |
2022-11-03 | 10Q | ASTE/Astec Industries Quarterly |
2022-08-03 | 10Q | ASTE/Astec Industries Quarterly |
2022-05-05 | 10Q | ASTE/Astec Industries Quarterly |
Receive ASTE News And Ratings
See the #1 stock for the next 7 days that we like better than ASTE
ASTE Financial Statistics
Sales & Book Value
Annual Sales: | $1.34B |
---|---|
Cash Flow: | $37.5M |
Price / Cash Flow: | 0 |
Annual Sales: | $28.73 |
Price / Book: | 1.18 |
Profitability
EPS (TTM): | 1.47000 |
---|---|
Net Income (TTM): | $33.5M |
Gross Margin: | $330.8M |
Return on Equity: | 5.24% |
Return on Assets: | 3.24% |
Astec Industries Earnings Forecast
Key Astec Industries Financial Ratios
- The Gross Profit Margin over the past 39 years for ASTE is 24.72%.
- The Selling, General & Administrative Expenses for ASTE have been equal to 20.65% of Gross Profit Margin.
- The Research & Development expenses have been 2.47% of Revenue.
- The Interest Expense is 26.57% of Operating Income.
- The Net Earning history of ASTE is 2.50% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 21 years.
Astec Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | ASTE |
CUSIP: | 046224 |
Website: | astecindustries.com |
Debt
Debt-to-Equity Ratio: | 0.13 |
---|---|
Current Ratio: | 2.41 |
Quick Ratio: | 0.78 |
Price-to-Earnings
Trailing P/E Ratio: | 22.97 |
---|---|
Forward P/E Ratio: | 10.86 |
ASTE Technical Analysis vs Fundamental Analysis
Sell
25
Astec Industries (ASTE)
is a Sell
Is Astec Industries a Buy or a Sell?
-
Astec Industries stock is rated a Sell
The current Astec Industries [ASTE] share price is $33.77. The Score for ASTE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.